Mar. 13, 2025 — A discovery about how severe COVID-19 damages lung cells suggests that an existing drug could treat ... Energy Bursts to Ventilator-Induced Lung Injury Mar. 3, 2025 — A new ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

It can be tough to know if a young person is using vapes, since they are typically compact and inconspicuous. The devices – ...

Despite glossy ads and social media hype, vaping is fueling a new health crisis among youth—marked by cancer, coma and ...

An editorial published in Brain Medicine raises the alarm about a previously overlooked threat to brain development and ...

A preclinical study by scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory ...

that could provide early readouts of the host-directed therapy and visualize lung scarring. If those trials are successful, he says, doctors might eventually add navitoclax or similar drugs to the ...

Down past New Orleans lies Plaquemines parish, a narrow sliver of land at the tip of Louisiana that reaches southward like a ...

AstraZeneca and partner Daiichi Sankyo have their first phase 3 data for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) – in lung cancer – in one of the most ...